Yasir is an Entrepreneur-in-Residence based in San Francisco. He is a seasoned executive, board member, and strategic advisor to biotech companies. Most recently, he was the President and CEO of Addition Therapeutics, a genetic medicine company, and currently serves as an independent board member for MaxCyte and Vicore Pharma. Prior to his CEO role, Yasir has had operational experience running finance and business development functions at both public and private biotech companies, and prior to that had senior roles in investment banking as both an equity analyst and in corporate finance, where he was involved in more than $30 billion in strategic and financial transactions.
Yasir started his career as a practicing physician, holding both clinical and academic medical posts. Dr. Al-Wakeel received his BM BCh (Doctor of Medicine and Surgery) from Oxford University and his MA in theology from Cambridge University.